Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
2024 Standout
Works of Anne Berberich being referenced
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma
2018
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anne Berberich | 119 | 121 | 119 | 16 | 334 | |
| Marc‐Alexander Brockmann | 135 | 171 | 46 | 18 | 365 | |
| Hirad Hedayat | 61 | 87 | 25 | 22 | 361 | |
| Tine Wyseure | 54 | 61 | 62 | 15 | 334 | |
| Theresa Czech | 83 | 70 | 44 | 16 | 267 | |
| Yohann Schmitt | 64 | 112 | 172 | 12 | 332 | |
| Monica Battiston | 39 | 48 | 84 | 19 | 356 | |
| Jasmin Jo | 62 | 60 | 128 | 19 | 279 | |
| N Peyri | 23 | 28 | 56 | 15 | 321 | |
| Anna R. Cooper | 166 | 93 | 180 | 14 | 333 | |
| Allard Wagenaar | 39 | 20 | 27 | 16 | 295 |
All Works
Login with ORCID to disown or claim papers
Loading papers...